EUVIMEDEUVIMED entdecken
Crossref

Preventive Antiarrhythmic Properties of Melatonin in Experimental Diabetic Cardiomyopathy in Rats

Alexey O Ovechkin iD, Mikhail A Gonotkov iD, Alena S Abramochkina iD, Ekaterina N Sedyakina iD, Aleksandra V Durkina iD, Olesya G Bernikova iD, Ilya O Velegzhaninov iD, Jan E Azarov iD

Journal of Pineal Research · 2026-07 · 78 (4)

DOI: 10.1111/jpi.70153 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pineal Research, online erschienen am 04.06.2026. Verfasst von Alexey O Ovechkin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Physiology, Institute of Physiology, Komi Science Center, Ural Branch of Russian Academy of Sciences, Syktyvkar, Komi Republic,…. Hauptthemen laut MEDLINE: Melatonin, Diabetic Cardiomyopathies, Diabetes Mellitus, Experimental, Anti-Arrhythmia Agents. Die Arbeit nennt 57 Literaturangaben. Gefördert von: Russian Academy of Sciences, Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus (DM) promotes cardiac arrhythmias, whereas melatonin confers antiarrhythmic effects. Cellular targets modified by DM and melatonin largely overlap, which warrants testing melatonin as an antiarrhythmic agent in DM. Herein, we evaluated electrophysiological and antiarrhythmic properties of melatonin in the experimental DM model. Experiments were performed in 41 control and 71 diabetic rats. 34 diabetic animals were treated with melatonin (orally, 10 mg/kg daily) for 1 month, and 37 diabetic animals received a placebo. Electrophysiological studies included electrocardiography, in vivo epicardial mapping with induction of ischemia‐reperfusion, and patch‐clamp studies in ventricular cardiomyocytes. Collagen deposition was assessed in postmortem histological studies. RT‐PCR and Western blotting methods were used to estimate Gja1 gene expression and Cx43 protein level, respectively. Melatonin treatment in diabetic animals did not influence the level of glycaemia, but mitigated the progression of myocardial fibrosis. Melatonin treatment prevented the DM‐related decrease in conduction velocity, increase in duration and dispersion of repolarization, as well as corresponding changes in their electrocardiographic correlates (QRS, QT, and Tpeak‐Tend intervals, respectively). Melatonin also prevented the development of reperfusion ventricular tachycardia/fibrillation. The patch‐clamp studies showed that melatonin treatment significantly reduced calcium current, prevented DM‐related action potential duration prolongation, but did not modify DM‐related increase in sodium current. RT‐PCR studies demonstrated that melatonin treatment prevented the DM‐related upregulation of Gja1 gene expression and increase in Cx43 level. Melatonin treatment of diabetic rats conferred antiarrhythmic effects associated with electrophysiological changes reflected in ECG parameters, which warrants further testing of melatonin in a clinical context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninDiabetic CardiomyopathiesDiabetes Mellitus, ExperimentalAnti-Arrhythmia AgentsArrhythmias, CardiacAnimalsRatsConnexin 43MaleElectrocardiographyRats, WistarMyocytes, Cardiac

Stichwörter der Autor:innen

ECGarrhythmiasdiabetes mellituselectrophysiologyfibrosisionic currentsischemia‐reperfusionmelatoninmyocardium

Substanzen

MelatoninConnexin 43Anti-Arrhythmia AgentsGja1 protein, rat

Autor:innen und Institutionen

  • Department of Cardiac Physiology, Institute of Physiology, Komi Science Center, Ural Branch of Russian Academy of Sciences, Syktyvkar, Komi Republic, Russia.
  • Department of Physiology, Pirogov Russian National Research Medical University, Moscow, Russia.
  • Institute of Medicine, Pitirim Sorokin Syktyvkar State University, Syktyvkar, Komi Republic, Russia.
  • Department of Radioecology, Institute of Biology, Komi Science Center, Ural Branch, Russian Academy of Sciences, Syktyvkar, Komi Republic, Russia.
  • Center for Molecular and Biological Technologies, ITMO University, Sankt-Petersburg, Russia.

ORCID-Profile: Alexey O Ovechkin, Mikhail A Gonotkov, Alena S Abramochkina, Ekaterina N Sedyakina, Aleksandra V Durkina, Olesya G Bernikova, Ilya O Velegzhaninov, Jan E Azarov

Förderung

  • Russian Academy of Sciences
  • Russian Science Foundation

Zitieren

APA

Ovechkin, A. O., Gonotkov, M. A., Abramochkina, A. S., Sedyakina, E. N., Durkina, A. V., Bernikova, O. G., Velegzhaninov, I. O., & Azarov, J. E. (2026). Preventive Antiarrhythmic Properties of Melatonin in Experimental Diabetic Cardiomyopathy in Rats. Journal of Pineal Research, 78(4). https://doi.org/10.1111/jpi.70153

Vancouver

Ovechkin AO, Gonotkov MA, Abramochkina AS, Sedyakina EN, Durkina AV, Bernikova OG, et al. Preventive Antiarrhythmic Properties of Melatonin in Experimental Diabetic Cardiomyopathy in Rats. Journal of Pineal Research. 2026;78(4). doi:10.1111/jpi.70153

BibTeX
@article{Ovechkin2026,
  author = {Ovechkin, Alexey O and Gonotkov, Mikhail A and Abramochkina, Alena S and Sedyakina, Ekaterina N and Durkina, Aleksandra V and Bernikova, Olesya G and Velegzhaninov, Ilya O and Azarov, Jan E},
  title = {Preventive Antiarrhythmic Properties of Melatonin in Experimental Diabetic Cardiomyopathy in Rats},
  journal = {Journal of Pineal Research},
  year = {2026},
  volume = {78},
  number = {4},
  doi = {10.1111/jpi.70153}
}
Kostenlos starten →